跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Botulinum toxin E
首页
药物
Botulinum toxin E
Botulinum toxin E
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for treating pain with botulinum toxin type B
US 6887476 B2
申请人: ALLERGAN INC
优先权: 2000
US
40 件公开
Systems and methods for delivery of a therapeutic agent
US 7608275 B2
申请人: FOUNDRY LLC
优先权: 2006
US
16 件公开
US 12433837 B2
申请人: FOUNDRY LLC
优先权: 2023
US
Soluble recombinant botulinum toxin proteins
US 2005238665 A1
申请人: ALLERGAN INC ALLERGAN BOTOX LT
优先权: 2002
US
7 件公开
Chimera botulinum toxin type E
US 7691983 B2
申请人: ALLERGAN INC
优先权: 2005
US
6 件公开
Method for preparing botulinum neurotoxin type A light chain
US 7465457 B2
申请人: WISCONSIN ALUMNI RES FOUND
优先权: 2006
US
4 件公开
Pharmaceutical Compositions Containing Botulinum Neurotoxin A2
US 2008069841 A1
申请人: PANJWANI NAVEED
优先权: 2004
EP
US
3 件公开
Method for treating a mucus secretion
US 6986893 B2
申请人: ALLERGAN INC
优先权: 2001
US
3 件公开
Escherichia coli-derived vaccine and therapy against botulism
US 2007059326 A1
申请人: BALDWIN MICHAEL
优先权: 2005
US
3 件公开
Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component
US 10266817 B2
申请人: NEXGEN BIOTECHNOLOGIES INC
优先权: 2016
CN
US
2 件公开
Botulinum neurotoxins for use in therapy
US 11260114 B2
申请人: BONTI INC
优先权: 2017
US
WO
2 件公开
第 1 / 4 页
上一页
下一页
药物
反馈